Mufg Securities Americas Inc. Purchases 2,292 Shares of UnitedHealth Group Incorporated $UNH

Mufg Securities Americas Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,352 shares of the healthcare conglomerate’s stock after purchasing an additional 2,292 shares during the quarter. Mufg Securities Americas Inc.’s holdings in UnitedHealth Group were worth $11,368,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $4,376,167,000. Corient Private Wealth LP purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $245,516,000. Legal & General Group Plc bought a new stake in UnitedHealth Group during the second quarter valued at approximately $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter worth $2,019,844,000. Finally, BlackRock Inc. lifted its holdings in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $393.99 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The stock’s 50 day simple moving average is $413.28 and its 200 day simple moving average is $360.11. The firm has a market cap of $353.64 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the prior year, the firm posted $4.08 earnings per share. The business’s quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is 59.72%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Mizuho raised their price target on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research report on Monday, July 20th. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Piper Sandler set a $477.00 target price on UnitedHealth Group in a research report on Thursday, July 16th. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Finally, Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.